Dépistage du cancer de la prostate: actualité

Browse by...

Deposit

Highlights

More informations

Title		Dépistage du cancer de la prostate: actualité
Authors		Tawadros, T Doerfler, A Treuthardt, Cécile Praz, Valentin Levi, F Zouhair, A Berthold, D Bauer, J Iselin, Christophe Jichlinski, P show all authors [1 - 10]
Published in		Revue médicale suisse. 2009, vol. 5, no. 228, p. 2438-41
Abstract		Prostate cancer screening using PSA is controversial because of a low specificity and detection of non clinically relevant cancer. Two important studies have been published recently. One of two studies suggests a 20% lowering in specific prostate cancer mortality due to PSA screening. This benefit is relevant but implies at a high risk of overtreatment and treatment-related complications. Currently PSA screening is only proposed as an individual screening for informed patients.
Keywords		Humans — Male — Prostate-Specific Antigen/blood — Prostatic Neoplasms/blood/diagnosis
Identifiers		PMID: 20088117
Full text		Article (Published version) (2.7 MB) - Limited access to UNIGE Other version: http://rms.medhyg.ch/numero-228-page-2438.htm
Structures		Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group		Groupe Iselin Christophe (urologie) (106)
Citation (ISO format)		TAWADROS, T et al. Dépistage du cancer de la prostate: actualité. In: Revue médicale suisse, 2009, vol. 5, n° 228, p. 2438-41. https://archive-ouverte.unige.ch/unige:32423